Earnings & Reporting

A new report shows patients are rejecting 'overdone' looks for subtle, strategic care, driven by Ozempic, menopause, and a desire for authenticity.

Life Time posts record 2025 earnings and a 230% Q4 profit surge, announcing a $500M share buyback and an aggressive expansion of its 'athletic country clubs'.

Scotiabank reports a strong start to 2026, with adjusted earnings beating forecasts as international divestitures and domestic growth signal a new focus.

Drilling at the Tesorito deposit has intersected a potential high-grade feeder zone, suggesting a much larger and richer system than previously modeled.

After a challenging year, iGaming affiliate Gentoo Media posts record Q4 profits, signaling a successful pivot to a leaner model ahead of a key refinancing.

The coffee giant posts impressive 2025 results amid high inflation, paving the way for its blockbuster acquisition by Keurig Dr Pepper. What's next?

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

The department store chain reported strong earnings that surpassed analyst estimates, but declining sales and margin pressure reveal a complex path forward.

Fresh off its first profitable year and with a new CEO, Remitly launches a major investor tour to detail its ambitious diversification strategy.

Industrial packaging giant Greif rewards shareholders, but a closer look at its finances and dual-class stock reveals a company in major transition.

The French banking giant finalizes a major capital reduction and progresses on a new buyback, signaling strong confidence and rewarding investors.

GameChange Energy acquires Terrasmart's eBOS unit, expanding its module-to-grid offerings and boosting U.S. solar manufacturing in a major industry shift.

Bitcoin miner Abits Group raises needed cash in a dilutive offering, sending its stock plunging and shining a spotlight on its controversial dealmaker.

With strong growth in key sectors but weakness in others, Plexus management faces a pivotal moment at the upcoming Raymond James investor conference.

Renoworks strengthens its board with a tech investment expert, signaling a strategic push to scale its AI platform and capitalize on the digital home market.

Mawer Investment Management names industry veteran Eric Wetlaufer as interim CEO, ensuring leadership continuity as Bruce Geddes takes a personal leave.

Amid financial headwinds, CISO Global appoints a new EVP to accelerate AI innovation, enhance operational efficiency, and gain a competitive edge.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.